tiprankstipranks
Trending News
More News >
National Healthcare Properties, Inc. (HLTC)
:HLTC
US Market

National Healthcare Properties (HLTC) AI Stock Analysis

Compare
25 Followers

Top Page

HL

National Healthcare Properties

(OTC:HLTC)

Rating:48Neutral
Price Target:
$8.00
▲(0.00%Upside)
The overall stock score is primarily influenced by the company's challenging financial performance, which is the most significant factor. Technical analysis and valuation scores also indicate areas of concern, although recent corporate events suggest some positive developments. The lack of earnings call data limits the analysis of forward-looking guidance.

National Healthcare Properties (HLTC) vs. SPDR S&P 500 ETF (SPY)

National Healthcare Properties Business Overview & Revenue Model

Company DescriptionHealthcare Trust, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States.
How the Company Makes MoneyNational Healthcare Properties generates revenue primarily through leasing and managing its portfolio of healthcare-related properties. The company earns rental income from long-term lease agreements with healthcare providers, including hospitals, outpatient facilities, and senior living communities. Additionally, HLTC may engage in strategic partnerships with healthcare operators to enhance property value and ensure high occupancy rates. The company's earnings are further bolstered by property appreciation and potential gains from the sale of select assets. By maintaining a diversified portfolio across different healthcare sectors, HLTC mitigates risk and capitalizes on the growing demand for healthcare services.

National Healthcare Properties Financial Statement Overview

Summary
National Healthcare Properties is struggling with declining revenues, high leverage, and negative cash flows. Persistent net losses and operational inefficiencies highlight the need for strategic improvements to stabilize financial health. High debt levels and negative free cash flow warrant caution for stakeholders.
Income Statement
35
Negative
The company has faced declining revenue with a negative revenue growth rate and consistently negative net income, impacting profitability. Margins like gross profit are relatively stable, but EBIT and EBITDA margins are negative, indicating operational challenges.
Balance Sheet
45
Neutral
The debt-to-equity ratio is high, reflecting significant leverage, which could pose financial risk. The equity ratio has decreased over time, and return on equity is negative due to persistent net losses, indicating potential financial instability.
Cash Flow
30
Negative
Operating cash flow has turned negative, impacting free cash flow, which is also negative. The free cash flow to net income ratio reflects challenges in generating cash relative to reported earnings, indicating cash flow concerns.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue353.79M345.77M335.85M329.36M381.61M
Gross Profit132.65M127.97M122.40M123.54M138.06M
EBITDA-36.49M81.14M79.79M82.57M92.61M
Net Income-189.70M-72.30M-79.62M-85.44M-75.51M
Balance Sheet
Total Assets1.95B2.15B2.18B2.21B2.29B
Cash, Cash Equivalents and Short-Term Investments21.65M46.41M53.65M59.74M72.36M
Total Debt1.15B1.18B1.12B1.09B1.23B
Total Liabilities1.26B1.24B1.18B1.17B1.33B
Stockholders Equity684.56M894.15M992.64M1.03B956.99M
Cash Flow
Free Cash Flow-101.75M-773.00K302.00K19.81M19.91M
Operating Cash Flow-79.85M21.62M28.30M38.88M41.81M
Investing Cash Flow63.97M-62.82M-41.78M-47.92M-82.49M
Financing Cash Flow-1.35M55.97M4.64M4.08M19.43M

National Healthcare Properties Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price8.00
Price Trends
50DMA
8.18
Negative
100DMA
7.65
Positive
200DMA
7.52
Positive
Market Momentum
MACD
0.18
Positive
RSI
26.70
Positive
STOCH
6.36
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HLTC, the sentiment is Neutral. The current price of 8 is below the 20-day moving average (MA) of 9.12, below the 50-day MA of 8.18, and above the 200-day MA of 7.52, indicating a neutral trend. The MACD of 0.18 indicates Positive momentum. The RSI at 26.70 is Positive, neither overbought nor oversold. The STOCH value of 6.36 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HLTC.

National Healthcare Properties Risk Analysis

National Healthcare Properties disclosed 82 risk factors in its most recent earnings report. National Healthcare Properties reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

National Healthcare Properties Peers Comparison

Overall Rating
UnderperformOutperform
Sector (59)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$469.56M-1.67%11.35%1.33%-149.80%
UHUHT
69
Neutral
$551.29M30.1810.15%7.44%0.95%15.07%
69
Neutral
$135.78M18.5136.40%5.13%22.41%37.88%
DHDHC
68
Neutral
$849.20M-13.96%1.14%5.33%10.68%
59
Neutral
C$1.22B0.72-8.20%5.66%9.89%-25.14%
58
Neutral
$472.25M207.991.45%9.22%-1.66%-86.24%
48
Neutral
$226.37M-22.64%0.78%-115.26%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HLTC
National Healthcare Properties
8.00
-2.00
-20.00%
DHC
Diversified Healthcare Trust
3.57
0.65
22.26%
CHCT
Community Healthcare
16.96
-3.90
-18.70%
GMRE
Global Medical REIT
6.74
-1.37
-16.89%
UHT
Universal Health Realty Income
40.11
4.00
11.08%
STRW
Strawberry Fields REIT Inc
10.75
0.38
3.66%

National Healthcare Properties Corporate Events

Shareholder Meetings
National Healthcare Properties Approves 2025 Incentive Plan
Neutral
May 23, 2025

On May 22, 2025, National Healthcare Properties, Inc. held its annual meeting where stockholders approved the 2025 Omnibus Incentive Compensation Plan. This plan allows directors and employees to participate, with a total of 1,900,000 shares available for issuance, plus an additional 6.5% of shares from future offerings until the initial public offering. The plan will expire on May 22, 2035. Additionally, stockholders re-elected directors and ratified PricewaterhouseCoopers LLP as the independent accounting firm for 2025.

Business Operations and StrategyFinancial Disclosures
National Healthcare Properties Reports Q1 2025 Financial Improvement
Positive
May 9, 2025

In the first quarter of 2025, National Healthcare Properties, Inc. reported improved financial performance with a significant reduction in net loss and increased funds from operations. The company executed strategic dispositions, reducing net leverage and enhancing its financial position, while continuing preparations for a public listing and future equity offerings.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 25, 2025